Inflammatory Bowel Diseases
Conditions
Brief summary
Inflammatory bowel diseases comprise two distinctive entities: Crohn's disease and ulcerative colitis. During the last decade, endoscopic assessment of inflammation has become relevant since it is a prognostic factor. As a consequence, therapeutic targets now contemplate mucosal healing as part of the goals to be achieved. Endoscopic scores for Crohn's disease and ulcerative colitis have been developed to objectively assess the mucosal inflammatory activity. Although they may have some limitations, these scores have been widely accepted in referral centers, especially since they have been adopted as standard evaluation in inflammatory bowel disease clinical trials . However, their use in the setting of endoscopic practice outside centers with a high volume or with less experience in clinical trials is not known.
Interventions
PROCEDUREcolonoscopy
endoscopic exploration of colonic mucosa to evaluate inflammatory activity in patients with either Crohn's disease or ulcerative colitis
Sponsors
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients who underwent colonoscopy for the evaluation of mucosal inflammatory activity * Patients with an established diagnosis of either Crohn's disease or ulcerative colitis
Exclusion criteria
* Sigmoidoscopies performed in ulcerative colitis for the assessment of mucosal inflammatory activity
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Endoscopic score report | January 2018-October 2022 | Proportion of colonoscopy reports among inflammatory bowel disease patients which include an endoscopic score to assess inflammatory activity |
Countries
Argentina
Contacts
Primary ContactJuan S Lasa, MD
Outcome results
None listed